BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 2553792)

  • 1. Nuclear enzymes, fragile sites, and cancer.
    Yunis JJ; Hoffman WR
    J Gerontol; 1989 Nov; 44(6):37-44. PubMed ID: 2553792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fragile sites are targets of diverse mutagens and carcinogens.
    Yunis JJ; Soreng AL; Bowe AE
    Oncogene; 1987 Mar; 1(1):59-69. PubMed ID: 3438083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of common chromosomal fragile site genes, WWOX/FRA16D and FHIT/FRA3B is downregulated by exposure to environmental carcinogens, UV, and BPDE but not by IR.
    Thavathiru E; Ludes-Meyers JH; MacLeod MC; Aldaz CM
    Mol Carcinog; 2005 Nov; 44(3):174-82. PubMed ID: 16187332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nickel (II) enhances benzo[a]pyrene diol epoxide-induced mutagenesis through inhibition of nucleotide excision repair in human cells: a possible mechanism for nickel (II)-induced carcinogenesis.
    Hu W; Feng Z; Tang MS
    Carcinogenesis; 2004 Mar; 25(3):455-62. PubMed ID: 14604891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Fragile sites on human chromosomes and cancer-specific chromosomal rearrangements].
    Hori T
    Gan To Kagaku Ryoho; 1986 Mar; 13(3 Pt 2):667-76. PubMed ID: 3963838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Benzo[a]pyrene diol epoxide and bleomycin sensitivity and susceptibility to cancer of upper aerodigestive tract.
    Wu X; Gu J; Hong WK; Lee JJ; Amos CI; Jiang H; Winn RJ; Fu KK; Cooper J; Spitz MR
    J Natl Cancer Inst; 1998 Sep; 90(18):1393-9. PubMed ID: 9747870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Benzo[a]pyrene diol epoxide-induced 9p21 aberrations associated with genetic predisposition to bladder cancer.
    Hazra A; Grossman HB; Zhu Y; Luo S; Spitz MR; Wu X
    Genes Chromosomes Cancer; 2004 Dec; 41(4):330-8. PubMed ID: 15390186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fragile sites, cancer chromosome breakpoints, and oncogenes all cluster in light G bands.
    Hecht F
    Cancer Genet Cytogenet; 1988 Mar; 31(1):17-24. PubMed ID: 3162186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic alterations in cancer as a result of breakage at fragile sites.
    Popescu NC
    Cancer Lett; 2003 Mar; 192(1):1-17. PubMed ID: 12637148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Further characterization of benzo[a]pyrene diol-epoxide (BPDE)-induced comet assay effects.
    Bausinger J; Schütz P; Piberger AL; Speit G
    Mutagenesis; 2016 Mar; 31(2):161-9. PubMed ID: 26346062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Removal of benzo(a)pyrene diol epoxide (BPDE)-DNA adducts as a measure of DNA repair capacity in lymphoblastoid cell lines from sisters discordant for breast cancer.
    Motykiewicz G; Faraglia B; Wang LW; Terry MB; Senie RT; Santella RM
    Environ Mol Mutagen; 2002; 40(2):93-100. PubMed ID: 12203401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Common fragile sites as targets for chromosome rearrangements.
    Arlt MF; Durkin SG; Ragland RL; Glover TW
    DNA Repair (Amst); 2006 Sep; 5(9-10):1126-35. PubMed ID: 16807141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fragile sites, mutagens and genomic rearrangements in cancer.
    Yunis JJ
    Basic Life Sci; 1988; 43():11-21. PubMed ID: 3284518
    [No Abstract]   [Full Text] [Related]  

  • 14. Benzo[a]pyrene diol epoxide-induced 3p21.3 aberrations and genetic predisposition to lung cancer.
    Wu X; Zhao Y; Honn SE; Tomlinson GE; Minna JD; Hong WK; Spitz MR
    Cancer Res; 1998 Apr; 58(8):1605-8. PubMed ID: 9563468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Benzo(a)pyrene diol epoxide-induced chromosomal aberrations and risk of lung cancer.
    Wei Q; Gu J; Cheng L; Bondy ML; Jiang H; Hong WK; Spitz MR
    Cancer Res; 1996 Sep; 56(17):3975-9. PubMed ID: 8752166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recurrent genomic rearrangements are not at the fragile sites on chromosomes 3 and 5 in human renal cell carcinomas.
    Kovacs G; Brusa P
    Hum Genet; 1988 Sep; 80(1):99-101. PubMed ID: 3417313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Common fragile sites associated with the breakpoints of chromosomal aberrations in hematologic neoplasms.
    Gümüş G; Sunguroğlu A; Tükün A; Sayin DB; Bökesoy I
    Cancer Genet Cytogenet; 2002 Mar; 133(2):168-71. PubMed ID: 11943347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of stably transfected human glutathione S-transferase P1-1 protects against DNA damage by benzo[a]pyrene diol-epoxide in human T47D cells.
    Fields WR; Morrow CS; Doss AJ; Sundberg K; Jernström B; Townsend AJ
    Mol Pharmacol; 1998 Aug; 54(2):298-304. PubMed ID: 9687571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early whole-genome transcriptional response induced by benzo[a]pyrene diol epoxide in a normal human cell line.
    Lu X; Shao J; Li H; Yu Y
    Genomics; 2009 Apr; 93(4):332-42. PubMed ID: 19150397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Benzo(a)pyrene diol epoxide-induced chromosome 9p21 aberrations are associated with increased risk of bladder cancer.
    Gu J; Horikawa Y; Chen M; Dinney CP; Wu X
    Cancer Epidemiol Biomarkers Prev; 2008 Sep; 17(9):2445-50. PubMed ID: 18768515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.